As a result, molecular classification has emerged to better categorize breast tumors according to hormone receptor (HR) expression and human epidermal growth factor receptor 2 (HER2) status, defining four main molecular subtypes—luminal A, luminal B, HER2-enriched and triple-negative breast cancer (TNBC) [3,4]. Here, ERBB2 is linked to triple-negative breast carcinoma.